Literature DB >> 26500245

Partial and intermediate atrioventricular septal defects without major associated cardiac anomalies.

Panagiotis Sfyridis1, Vladimir Sojak2, Mark Hazekamp2.   

Abstract

Partial and intermediate atrioventricular septal defects (p-i AVSDs) constitute approximately 20-40% of all AVSDs. Children with p-i AVSDs are usually asymptomatic and typically undergo surgery at the preschool age or earlier if the signs of heart failure have developed. Surgical treatment for repair of p-i AVSDs has been successful for more than 60 years and is mainly directed towards closing septal defects, and maintaining or creating competent, non-stenotic left and/or right atrioventricular valves. By most measures, the outcomes of surgical management of p-i AVSDs have improved over the last 5 decades. In spite of significantly reduced mortality, the need for reoperation and long-term morbidity remains an issue in some patients from this population. The purpose of this article is to review current options and outcomes concerning the surgical management of the p-AVSD and i-AVSD variants without major associated cardiac malformations.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Partial and intermediate atrioventricular septal defect

Mesh:

Year:  2015        PMID: 26500245     DOI: 10.1093/mmcts/mmv033

Source DB:  PubMed          Journal:  Multimed Man Cardiothorac Surg        ISSN: 1813-9175


  2 in total

1.  Dissociation of right and left AV conduction: What is the mechanism?

Authors:  Federica Torri; Angela Maria Zedda; Livio Bertagnolli; Roman A Gebauer; Gerhard Hindricks; Arash Arya
Journal:  HeartRhythm Case Rep       Date:  2016-10-19

2.  Repair of partial atrioventricular canal defect in adult patients: two-year follow-up outcomes of a retrospective study.

Authors:  Lingyun Song; Yunfei Ling; Qi An
Journal:  J Cardiothorac Surg       Date:  2019-06-11       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.